Skip to main content
Clinical Trials/ISRCTN91104012
ISRCTN91104012
Active, not recruiting
未知

Effectiveness and cost-effectiveness of a multimodal programme as coadjuvant treatment in people with a diagnosis of long COVID-19 from primary health care: a randomised clinical trial

Instituto de Salud Carlos III0 sites100 target enrollmentFebruary 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
ong COVID-19
Sponsor
Instituto de Salud Carlos III
Enrollment
100
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36612782/ (added 02/03/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37193738/ results (added 17/05/2023)

Registry
who.int
Start Date
February 10, 2022
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Instituto de Salud Carlos III

Eligibility Criteria

Inclusion Criteria

  • Current participant inclusion criteria as of 11/03/2022:
  • 1\. Individuals over the age of 18 years
  • 2\. Suffering from long COVID\-19
  • 3\. From Primary Health Centers of Aragón (Spain)
  • 4\. Understand written and spoken Spanish
  • 5\. Have provided their informed consent
  • 6\. Who are not undergoing training or rehabilitation through respiratory physiotherapy, physical activity, or cognitive stimulation
  • Previous participant inclusion criteria:
  • 1\. Individuals over the age of 18 years
  • 2\. Suffering from long COVID\-19

Exclusion Criteria

  • 1\. Presence of serious uncontrolled medical illness, which may interfere with compliance with the activities and recommendations
  • 2\. Risk of suicide
  • 3\. Pregnancy or lactation
  • 4\. Patients who have participated in another clinical trial over the past 6 months
  • 5\. Are currently receiving structured psychotherapeutic treatment by a mental health professional over the past 6 months
  • 6\. The presence of any medical, psychological or social problem that could seriously interfere with the patient’s participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials